Depression in CADASIL patients by Lačković Maja et al.
Arch. Biol. Sci., Belgrade, 66 (3), 1187-1194, 2014 DOI:10.2298/ABS1403187L
1187
DEPRESSION IN CADASIL PATIENTS
MAJA LAČKOVIĆ1,2, ALEKSANDAR DAMJANOVIĆ1,2, MAJA IVKOVIĆ1,2, MAJA PANTOVIĆ1, 
MILOŠ BAJČETIĆ 3, BRANISLAV ROVČANIN4, ALEKSANDRA PAVLOVIĆ2,5, NADEŽDA ŠTERNIĆ2,5 
and MIROSLAVA JAŠOVIĆ-GAŠIĆ1,2
1 Psychiatry Clinic, Clinical Center of Serbia, 11000 Belgrade, Serbia 
2 School of Medicine, University of Belgrade, 11000 Belgrade, Serbia 
3 Institute of Histology and Embryology, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia 
4 Institute for Human Genetics, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia 
5 Neurology Clinic, Clinical Center of Serbia,11000 Belgrade, Serbia
Corresponding author: majalacko@eunet.rs
Abstract – Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is 
a hereditary neurological disease accompanied by recurrent ischemic events, characterized by the presence of psychiatric 
disorders. The aim of this study was to examine the occurrence of depression and its severity among patients with CA-
DASIL. Sixteen patients with diffuse white matter changes on MRI and clinical signs suggesting CADASIL were included 
in the study. Definitive diagnosis of CADASIL was obtained by electron microscopic analysis of skin biopsies. Testing 
of the patients’ affective status was primarily devoted to detecting depression. Electron microscopic examinations of all 
skin biopsies revealed numerous granular osmiophilic material (GOM) deposits embedded into the basal lamina around 
altered or degenerated vascular smooth muscle cells (VSMCs). Clinical symptoms of depression were present in a great 
number of examined CADASIL patients. The frequency of depression was higher than previously reported. Psychiatric 
disturbances might also represent the onset of CADASIL, especially in young patients, and should be evaluated by dif-
ferential diagnosis.
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INTRODUCTION
Cerebral autosomal dominant arteriopathy with sub-
cortical infarcts and leukoencephalopathy (CADAS-
IL) is a hereditary neurological disease accompanied 
by  recurrent  ischemic  events  (Tournier-Lasserve, 
1993). It is rare nonamyliod and nonatherosclerotic 
disease of small and medium brain arteries. Patho-
logical changes are not exclusively localized in the 
brain, but they can also be found in the small blood 
vessels of almost all organs (Andre, 2010). 
CADASIL is caused by a defective Notch3 gene 
that is located in chromosome 19p13.1. Over 170 
mutations have been described so far, and they in-
duce progressive degeneration of vascular smooth 
muscle cells (VSMC), thickening and fibrosis of the 
vascular wall as well as an accumulation of granular 
osmiophilic material (GOM) in the basal lamina of 
VSMCs (Dichgans, 2002). These vascular changes 
cause ischemic brain events that subsequently lead 
to cognitive decline and often dementia (Kalimo et 
al., 2002). The presence of GOM is a pathognomonic 1188 MAJA LAČKOVIĆ ET AL.
hallmark in CADASIL. Considering that GOM de-
posits have also been detected within dermis blood 
vessels, a skin biopsy is the most commonly used 
diagnostic tool (Rouchoux et al., 1995). CADASIL 
is characterized by four common manifestations: 1) 
ischemic strokes, 2) migraine with aura, 3) psychi-
atric symptoms and 4) cognitive decline leading to 
subcortical vascular dementia. However, the disease 
is not associated with common risk factors such as 
hypertension  and  increased  cholesterol  levels,  as 
is the case among other ischemic strokes (Bousser 
and Tournier-Lasserve, 2001). Due to its slow and 
unpredictable progression, it is very hard to access 
therapeutic effects and regrettably, only symptomat-
ic therapy is available for now (Chabriat et al., 2000). 
Although neurological symptoms are the most fre-
quent feature of CADASIL, this disease is also char-
acterized by the presence of psychiatric disorders 
that are not enough described in previous literature 
(Lačković et al., 2008, Lačković, 2010, Valenti et al., 
2011). Meta-analysis that included all studies based 
on psychiatric disorders in CADASIL patients in the 
period from 1997 to 2007 showed that the studies 
poorly and rarely focused on psychiatric events and 
psychopathological aspects of CADASIL (Valenti et 
al., 2008). Taylor and Doody (2008) reported that 
psychiatric  manifestations  have  been  detected  in 
30-40% of patients positively diagnosed with CA-
DASIL. Psychiatric disorders most often appear in 
the progressive phase of the disease, and are rarely 
its first manifestations. In a French study that in-
cluded 45 patients, 4.4% of patients had psychiatric 
manifestations as initial symptoms (Chabriat et al., 
1995). However, a German study that included 102 
CADASIL patients found this rate to be just above 
1% (1.2%) (Dichgans et al., 1998). Mood disorders 
are the most common psychiatric manifestation of 
CADASIL and they are present in one-fifth of these 
patients (Chabriat and Bousser, 2007). Episodes of 
major depression have been described in about 10% 
of the 80 CADASIL patients in the study of Peters et 
al. (2005). Furthermore, it has recently been shown 
that apathy is common in CADASIL. It can be as-
sociated  with  cognitive  decline,  global  functional 
disability  and  severe  neuropsychiatric  symptoms 
during the course of the disease, and can occur as 
a phenomenon separate from depression (Reyes et 
al., 2009).
The aim of this study was to assess the occur-
rence of depression and its severity among patients 
positively diagnosed with CADASIL using electron 
microscopy of skin biopsies. 
MATERIALS AND METHODS
Subjects
This  prospective  study  included  16  patients  hos-
pitalized  at  the  Neurology  Clinics  at  the  Clinical 
Center of Serbia and Military Medical Academy in 
Belgrade, Serbia, from 2001 to 2011. The inclusion 
criteria were diffuse white matter changes on MRI 
and clinical signs suggesting CADASIL. Definitive 
diagnosis of CADASIL was obtained with electron 
microscopic  analysis  of  skin  biopsies.  Psychiatric 
evaluation was accessed at Clinic of Psychiatry (Clin-
ical Center of Serbia) by a trained psychiatrist. Each 
patient  underwent  a  medical  examination  and  an 
interview in order to screen for the presence of risk 
factors for cerebrovascular disease, such as hyperten-
sion, lipid status, cardiac diseases with and without 
rhythm disorders, coagulation status, smoking and 
family anamnesis. In order to exclude antiphospholi-
pid syndrome, the level of circulating anticoagulants 
(lupus  anticoagulant  and  anticardiolipin  antibod-
ies) was assessed for each patient. Table 1 describes 
demographic characteristics, risk factors and family 
anamnesis of the CADASIL patients.
Ultrastructural analysis
Samples of skin biopsy from the deltoid region were 
fixed in 3% glutaraldehyde and post-fixed in 1% os-
mium tetroxide overnight at +4ºC for 1 h, respective-
ly. Both glutaraldehyde and osmium tetroxide were 
dissolved in cacodylate buffer (0.1 mol/l, pH=7.4). 
After  dehydration  in  linear  ascending  gradient  of 
ethanol concentration, tissue samples were embed-
ded in 4.8 ml of Epon (Epoxy Embedding Medium), 
1.7 ml of DDSA (dodecenyl succinic anhydride) and 
0.2 ml BDMA (N-benzyldimethylamine). Semi-thin DEPRESSION IN CADASIL PATIENTS 1189
sections of skin were stained with a mixture of 1% 
toluidine blue and 1% azure A in 1% aqueous solu-
tions of borax and observed under light microscopy 
in order to select the most representative small ar-
tery or arterioles in the deep dermal tissue. Stained 
sections were observed under a light microscope and 
photomicrographs  were  taken  using  an  Olympus 
BX41 microscope. All the slides were photo docu-
mented  by  an  Olympus  C-5060  ADU  wide  zoom 
camera and the Olympus DP-soft Image Analyzer 
program.  Ultra-thin  sections  where  mounted  on 
copper grids, stained with uranyl acetate and lead 
citrate  and  examined  with  transmission  electron 
microscope  (Fei  Morgagni  268D,  Eindhoven,  The 
Netherlands). The transmission electron microscope 
was equipped with a MegaViewIII Soft Imaging Sys-
tem digital camera (Olympus Soft Imaging Solutions 
GmbH, Münster, Germany). 
Assessment of depression
The testing of the patients’ affective status was pri-
mary devoted to detecting depression. One of the 16 
patients with CADASIL was not enrolled in the study 
due to a lack of compliance during testing. The Ham-
ilton Rating Scale for Depression (HRSD) was used 
to assess the severity of present depressive symptoms 
(Hamilton 1960, Hamilton, 1967). This scale consists 
of 21 items evaluating mood, inhibition, feelings of 
guilt, suicidal thoughts, psychomotor agitation, anx-
iety, self-criticism, disorders of appetite and sleep. 
HRSD takes into account the somatic manifestation 
of depression, which makes it suitable for patients 
who lack insight into their depressiveness. This scale 
is not designed especially for dementia patients with 
depression so that errors are possible. Dementia pa-
tients often have somatic complaints not due to de-
pression, and on the other hand, they can have prob-
lems in answering some cognitive questions from the 
scale (Pavlović, 2002, Pavlović et al., 2003).
Data analysis
Statistical analysis of the collected data included de-
scriptive and inferential methods. The database was 
analyzed using the Software Package for Social Sci-
ences for Windows v. 14.0 (SPSS Inc. Chicago, IL). 
The  normality  of  distribution  was  tested  by  Kol-
mogorov-Smirnov test. Difference significance was 
examined using the Student’s t-test, Fischer’s accu-
rate probability test and Mann-Whitney U-test. Dif-
ferences were considered significant at p<0.05. 
Ethics
The study was approved by the Local Ethical Com-
mittee and carried out in accordance with the codex 
of good scientific practice of the Faculty of Medicine, 
University Belgrade.
RESULTS
Subject data
The subjects’ gender distribution, family anamnesis, 
existence of vascular risk factors, clinical signs and 
manifestations are shown at Table 1. The mean age of 
the patients was 48.81 ± 9.55 years.
Ultrastructural analysis
  Diagnosis of CADASIL was confirmed using 
electron microscopic analysis of skin biopsies of each 
patient. Semi-thin sections of skin displayed dermal 
small blood vessels with thickened, sometimes disin-
tegrated, vascular walls and narrowed or occasion-
ally obliterated lumen (Fig. 1). Electron microscopic 
examination of all skin biopsies revealed numerous 
GOM deposits of different texture embedded into 
thickened basal lamina around altered or degener-
ated VSMCs (Fig. 2). Occasionally granular deposits 
were found free between altered VSMCs. These de-
posits were observed most frequently in the shallow 
or deep indentations of VSMC plasma membrane 
embedded in the thickened basal lamina (Fig. 3). The 
number of GOM deposits varied between patients as 
well as their size, shape, electron density and granu-
lar composition.
Assessment of depression
Using the 21-item HRSD, depression was detected 1190 MAJA LAČKOVIĆ ET AL.
in 11/15 (73.3%) patients with CADASIL. All 11 pa-
tients showed moderate rate of depression, with a 
mean score of 16.93±6.55. Table 2 gives the distribu-
tion of depression rates. 
DISCUSSION
Skin biopsies of the CADASIL patients showed sig-
nificant  alterations  in  the  structural  organization 
of small blood vessels’ vascular walls. VSMCs were 
more or less degenerated and GOM was observed 
in all cases, which implies the correct diagnosis of 
CADASIL, since GOM is a specific histopathologi-
cal hallmark of this disease. Ultrastructural analysis 
remains the golden standard for CADASIL diagnosis 
(Lackovic et al., 2012). According to many previous 
researches, it can be assumed that morphological fac-
tors could play an important role in CADASIL patho-
genesis (Miao et al., 2004, Miao et al., 2006, Kalimo 
et al., 2008, Tikka et al., 2009). On the other hand, 
a relatively small number of studies determined that 
brain perfusion is reduced and insufficient to satisfy 
regular needs. Oxygen extraction level is increased in 
asymptomatic and demented patients with CADAS-
IL (Chabriat et al., 1995). Cerebral flow and blood 
volume as well as cerebral utilization of glucose are 
significantly decreased (Chabriat et al., 2000, Bruen-
ing et al., 2001, Pfefferkorn et al., 2001). Cerebral va-
soreactivity is damaged, which is in accordance with 
our results of degenerated VSMCs in small cerebral 
arteries and arterioles. Beside damaged VSMCs, there 
is a dissociation of myoendothelial junctions, includ-
ing changes in gap junctions and alterations of focal 
adhesions (Lackovic at al. 2008). All this points to the 
high fragility of small cerebral blood vessels, which 
is confirmed by the increased frequency of cerebral 
Table 1. Gender distribution, family anamnesis, vascular risk factors, clinical signs and manifestations of CADASIL patients.
Parameter      N        %
Gender 
   Male        8        50.0
   Female        8        50.0
Family anamnesis
   Positive                    10      62.5
   Negative         4        25.0
   Not acquired       2        12.5
Vascular risk factors
   Hypertension      5        31.2
   Smoking      5        31.2
   Increased cholesterol     4        25.0      
Clinical signs and manifestations
   Headache       11      68.8
   Hemiparesis      11      68.8
   Stroke         11      68.8
   Epileptic seizures        -          -                      
   TIA         -          -
                N – number of patients        % - percent
Table 2. The distribution of depression rates.
    Depression                    Without       Mild       Moderate       Severe  
           N, %          4 (26.7%)        -       11 (73.3%)         -             
    N,% – number of patients and percent of totalDEPRESSION IN CADASIL PATIENTS 1191
microhemorrhages observed in autopsies and MRI 
analyses (Dichgans, 2002). Since all our patients had 
prominent subcortical vascular changes and altered, 
degenerated and narrowed small blood vessels, in-
cluding prominent fi  brosis, the previous statements 
lead to the consideration of mood disorders in CA-
DASIL as part of the concept of vascular depression 
(Alexopoulos et al., 1997). Most of our patients were 
clinically depressed (73.3%) and the HRSD rate of 
depression was moderate in all of them. Depression 
is a leading cause of disability, diminished or lost 
productivity, increased use of health care resources, 
and is can also be associated with a decreased quality 
of life and increased mortality across all age groups 
(Stojanović-Špehar et al., 2010).
A large number of studies investigated a possible 
relation between vascular disorder and depression, 
leading  to  the  formulation  of  the  hypothesis  that 
connects etiology and clinical presentation. Such hy-
potheses are “vascular depression” and “post-stroke 
depression”.  Alexopoulos  et  al.,  (1997)  presumed 
that the depression that appears in the late phase of 
disease is characterized by specifi  c symptoms such 
as cognitive dysfunction, psychomotor retardation, 
lack of insight and depressive ideation. According to 
this research, the disruption of prefrontal pathways 
caused by ischemic lesions of white matter has a key 
role in the pathogenesis of depression. Based on the 
biological substrate in the etiology of post-stroke de-
pression, two hypotheses have been proposed. One 
considers the role of biogenic amines as important 
in generating psychiatric disorders and the other the 
role of cytokines. According to the biogenic amine 
theory, ischemic brain lesions can interrupt ascend-
ant axons that come from the brain stem and con-
tain biogenic amines. Th   is leads to a decrease in the 
overall production of serotonin and noradrenalin in 
non-damaged areas of the axonal trunk. Th   e conse-
quential  dysfunction  of  strategic  limbic  structures 
in the frontal and temporal cortices, as well as the 
basal ganglia, is able to induce clinical symptoms of 
depression (Robinson and Bloom, 1977). Th   e theory 
about the role of cytokines in psychiatric disorders 
is based on the results of an experiment that showed 
that an increase of proinfl  ammatory cytokines (IL-
1β and TNF-α) aft  er cerebral stroke can induce de-
pression-like behavior in experimental mice similar 
to the vegetative symptoms of depression in men. 
Several  studies  demonstrated  high  levels  of  IL-1β 
and TNF-α among patients with major depressive 
disorder and dysthymia (Maes et al., 1993, Levine 
Fig. 1. Dermal arteriole (semi-thin sections, toluidine blue, X320). Epidermis (1), dermis (2), slightly narrowed blood vessel lumen (3), 
endothelium (4), fragmented vascular smooth muscle cells (5) and signifi  cantly thickened vascular wall (6). 1192 MAJA LAČKOVIĆ ET AL.
et al., 1999). Two studies have also found that IL-18 
was overexpressed in the serum of depressed patients 
(Merendino et al., 2002, Kokai et al., 2002). Although 
the hypothesis that proinfl  ammatory cytokines may 
mediate post-stroke depression is proposed, it will be 
diffi   cult to prove that any of the proposed cytokines 
are central to the mechanism of post-stroke depres-
sion (Spalleta, 2006). 
Modern research has considered the correlation 
of  MRI  fi  ndings  and  neuropathological  changes, 
especially white matter hyperintensity, in order to 
examine  the  importance  of  cerebral  pathological 
changes in the pathogenesis of depression. Th   omas 
et al., (2002) demonstrated that all changes in de-
pressive patients comprise ischemic damages, sup-
porting the “vascular depression” hypothesis, which 
states that vascular diseases are a predisposing factor 
for the appearance and maintenance of depression. 
Th   ey also showed that all changes are ischemic, ap-
pearing as hyperintensive regions on MRI, and that 
they are located in the prefrontal lobe in depressive 
patients. Spot lesions were more frequent than usual 
and they were considered as predictors of depres-
sion. 
Studies to date suggest that the CADASIL phe-
notype is variable not only between families but also 
within them (Opherk et al., 2006, Adib-Samii et al., 
2010). Th   is could explain the rarest CADASIL cases 
where  psychiatric  symptoms  including  depression 
represented the onset of disease (Valenti et al., 2008, 
Taylor et al., 2008). Early psychiatric manifestations 
are of the utmost importance in diff  erential diagno-
sis of CADASIL since they can remain misdiagnosed 
for a long period of time (Haritunians et al., 2005). 
Fig.  3.  Same  arteriole  wall  part  at  higher  magnifi  cation  (X 
25.000), which is highlighted with a rectangle in Fig. 2. GOMs 
are  visualized  as  dark  deposits  (1)  around  altered  vascular 
smooth muscle cells (2). Note that GOMs are embedded in the 
basal lamina (3) and located in the invaginations of vascular 
smooth muscle cells. 
Fig. 2. Electron micrograph (X 5.000) of dermis arteriole with 
the  appearance  of  numerous  GOM  deposits  (arrowheads) 
around altered vascular smooth muscle cells (1). DEPRESSION IN CADASIL PATIENTS 1193
CONCLUSIONS
This  study  revealed  that  depression  is  frequent  in 
CADASIL patients. The frequency of depression was 
higher than previously reported. It is important to 
determine which psychiatric disorders develop dur-
ing  CADASIL  progression,  in  order  to  assign  ad-
equate therapy and to improve patients’ quality of 
life. We suggest that if psychiatric symptoms such as 
depression appear in relatively older patients and/
or patients who don’t respond adequately to applied 
psychopharmacotherapy, MRI should be performed. 
If MRI analysis uncovers leukoencephalopathy in the 
absence of cardiovascular risk factors and positive 
family  anamnesis  of  stroke  and/or  dementia,  CA-
DASIL can be suspected. Subsequently, a skin biopsy 
should be performed so that the correct diagnosis 
can be made. In addition, special attention should be 
paid to the appearance of early psychiatric symptoms 
in cases of positive family history, since a long time 
before the correct diagnosis is made, mood distur-
bances, including depression, may represent the first 
manifestation of CADASIL. 
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